• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

足分支霉病诊断的进展:探索新策略与新兴技术

Advancements in Diagnosing Talaromycosis: Exploring Novel Strategies and Emerging Technologies.

作者信息

Wang Yihui, Wang Xiaoyue, Xi Liyan, Lu Sha

机构信息

Department of Dermatology and Venereology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.

出版信息

J Fungi (Basel). 2025 Jun 6;11(6):434. doi: 10.3390/jof11060434.

DOI:10.3390/jof11060434
PMID:40558946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12194118/
Abstract

Talaromycosis (TM) is an invasive fungal infection caused by (). It has high morbidity and mortality rates, particularly among immunocompromised people. Globally, approximately 17,300 cases and 4900 deaths are reported annually. TM often has vague clinical signs with limited current tests, leading to misdiagnosis, incorrect treatments, or the long-term use of expensive antifungal drugs, which raises healthcare costs and patient risks. Although accurate diagnosis is key for starting the right antifungal therapy and improving outcomes, there are not enough reliable and fast tests. Recent progress with monoclonal antibodies (mAbs) that have high specificity for antigens may boost diagnostic accuracy and cut misdiagnosis rates. This review explores current ways to diagnose TM, including culture, histopathology, and molecular methods such as polymerase chain reaction (PCR) and antigen detection. We also discuss the merits and weaknesses of each method and highlight how mAbs may help diagnose TM. We searched PubMed, Web of Science, and Google Scholar for English-language papers (1990-1 January 2025) using "Talaromycosis" OR "" plus diagnostic terms ('diagnosis', 'molecular diagnostics', 'monoclonal antibody', 'lateral flow', 'antigen detection', and 'fungal diagnosis'). After deduplication and relevance screening, studies with original data or substantive discussion on diagnostics or mAb development were retained to inform this narrative review.

摘要

足分支霉病(TM)是一种由()引起的侵袭性真菌感染。其发病率和死亡率很高,在免疫功能低下人群中尤为如此。在全球范围内,每年报告约17300例病例和4900例死亡。TM的临床症状往往不明确,目前的检测手段有限,导致误诊、治疗不当或长期使用昂贵的抗真菌药物,这增加了医疗成本和患者风险。尽管准确诊断是开始正确抗真菌治疗并改善预后的关键,但可靠且快速的检测方法并不够。对抗原具有高特异性的单克隆抗体(mAb)的最新进展可能会提高诊断准确性并降低误诊率。本综述探讨了目前诊断TM的方法,包括培养、组织病理学以及分子方法,如聚合酶链反应(PCR)和抗原检测。我们还讨论了每种方法的优缺点,并强调了mAb在TM诊断中的作用。我们在PubMed、科学网和谷歌学术上搜索了1990年至2025年1月1日的英文论文,使用“足分支霉病”或“”加上诊断术语(“诊断”、“分子诊断”、“单克隆抗体”、“侧向流动”、“抗原检测”和“真菌诊断”)。经过重复数据删除和相关性筛选,保留了具有原始数据或对诊断或mAb开发进行实质性讨论的研究,以为本叙述性综述提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d1/12194118/5e08c01a4511/jof-11-00434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d1/12194118/e53ee418c58d/jof-11-00434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d1/12194118/fecbf6007eac/jof-11-00434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d1/12194118/5e08c01a4511/jof-11-00434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d1/12194118/e53ee418c58d/jof-11-00434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d1/12194118/fecbf6007eac/jof-11-00434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d1/12194118/5e08c01a4511/jof-11-00434-g003.jpg

相似文献

1
Advancements in Diagnosing Talaromycosis: Exploring Novel Strategies and Emerging Technologies.足分支霉病诊断的进展:探索新策略与新兴技术
J Fungi (Basel). 2025 Jun 6;11(6):434. doi: 10.3390/jof11060434.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
6
Blood biomarkers for the non-invasive diagnosis of endometriosis.用于子宫内膜异位症无创诊断的血液生物标志物。
Cochrane Database Syst Rev. 2016 May 1;2016(5):CD012179. doi: 10.1002/14651858.CD012179.
7
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
8
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
9
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.快速分子检测结核分枝杆菌和结核分枝杆菌耐药性:受检者和提供者观点的定性证据综合评价。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD014877. doi: 10.1002/14651858.CD014877.pub2.
10
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.

本文引用的文献

1
Clinical Diagnostic Challenge in a Case of Disseminated Infection Misdiagnosed Initially as Pulmonary Tuberculosis: A Case Report and Literature Review.一例最初误诊为肺结核的播散性感染病例的临床诊断挑战:病例报告及文献综述
Infect Drug Resist. 2024 Aug 29;17:3751-3757. doi: 10.2147/IDR.S471938. eCollection 2024.
2
Clinical performance of metagenomic next-generation sequencing for diagnosis of invasive fungal disease after hematopoietic cell transplant.造血细胞移植后宏基因组下一代测序诊断侵袭性真菌病的临床性能。
Front Cell Infect Microbiol. 2024 Mar 25;14:1210857. doi: 10.3389/fcimb.2024.1210857. eCollection 2024.
3
Disseminated infection after renal transplantation: A case report and literature review.
肾移植后播散性感染:病例报告及文献复习。
Front Cell Infect Microbiol. 2023 Feb 2;13:1115268. doi: 10.3389/fcimb.2023.1115268. eCollection 2023.
4
Advances in diagnosis and treatment of talaromycosis in patients with AIDS.艾滋病患者足分支菌病的诊断与治疗进展
Chin Med J (Engl). 2022 Nov 20;135(22):2687-2689. doi: 10.1097/CM9.0000000000002506.
5
An Overlooked and Underrated Endemic Mycosis-Talaromycosis and the Pathogenic Fungus Talaromyces marneffei.被忽视和低估的地方病真菌病——马尔尼菲篮状菌病和致病真菌马尔尼菲篮状菌。
Clin Microbiol Rev. 2023 Mar 23;36(1):e0005122. doi: 10.1128/cmr.00051-22. Epub 2023 Jan 17.
6
MALDI-TOF MS-Based Clustering and Antifungal Susceptibility Tests of Isolates from Fujian and Guangxi (China).基于基质辅助激光解吸电离飞行时间质谱的中国福建和广西分离株聚类及抗真菌药敏试验
Infect Drug Resist. 2022 Jul 1;15:3449-3457. doi: 10.2147/IDR.S364439. eCollection 2022.
7
Monoclonal Antibodies and Invasive Aspergillosis: Diagnostic and Therapeutic Perspectives.单克隆抗体与侵袭性曲霉病:诊断与治疗视角。
Int J Mol Sci. 2022 May 16;23(10):5563. doi: 10.3390/ijms23105563.
8
Clinical Characteristics, Laboratory Findings, and Prognosis in Patients With Infection Across Various Immune Statuses.不同免疫状态下感染患者的临床特征、实验室检查结果及预后
Front Med (Lausanne). 2022 Apr 15;9:841674. doi: 10.3389/fmed.2022.841674. eCollection 2022.
9
Talaromyces marneffei Mp1p Antigen Detection may Play an Important Role in the Early Diagnosis of Talaromycosis in Patients with Acquired Immunodeficiency Syndrome.马尔尼菲青霉 Mp1p 抗原检测可能在艾滋病患者中马尔尼菲青霉病的早期诊断中发挥重要作用。
Mycopathologia. 2022 Jun;187(2-3):205-215. doi: 10.1007/s11046-022-00618-9. Epub 2022 Mar 3.
10
A global call for talaromycosis to be recognised as a neglected tropical disease.呼吁将足放线菌病确认为被忽视的热带病。
Lancet Glob Health. 2021 Nov;9(11):e1618-e1622. doi: 10.1016/S2214-109X(21)00350-8.